JW (Cayman) Therapeutics Co. Ltd (HKG:2126)

HKG:2126 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	646.88	757.38	1,006	1,383	1,834	2,631
Short-Term Investments	-	5.16	5.53	5.54	0.7	0.86
Cash & Short-Term Investments	646.88	762.53	1,011	1,389	1,835	2,631
Cash Growth	-25.56%	-24.61%	-27.18%	-24.32%	-30.26%	932.14%
Accounts Receivable	25.06	-	-	5.31	-	-
Other Receivables	3.68	9.95	5.92	27.39	15.83	9.75
Receivables	28.74	9.95	5.92	32.7	15.83	9.75
Inventory	67.02	31.26	34.78	40.16	31.4	0.96
Restricted Cash	-	-	-	-	-	3.26
Other Current Assets	4.41	4.93	15.34	23.43	12.72	1.93
Total Current Assets	747.05	808.67	1,067	1,485	1,895	2,647
Property, Plant & Equipment	240.27	273.88	341.13	393.22	365.68	307.86
Other Intangible Assets	417.54	582.97	711.22	893.68	816.29	774.97
Other Long-Term Assets	14.59	14.85	26.27	19.28	39.6	49.3
Total Assets	1,419	1,680	2,146	2,791	3,117	3,779
Accounts Payable	79.11	40.15	53.67	71.16	72.08	24.38
Accrued Expenses	25.54	29.74	51.03	75.49	88.26	55.68
Short-Term Debt	-	-	-	137.3	-	-
Current Portion of Long-Term Debt	320.51	361.63	105	5	5	-
Current Portion of Leases	11.46	14.63	16.01	10.6	15.19	10.88
Current Unearned Revenue	30.04	16.81	31.42	1	1.44	6.79
Other Current Liabilities	3.69	2.11	7.34	10.29	16.93	139.32
Total Current Liabilities	470.35	465.05	264.47	310.84	198.9	237.05
Long-Term Debt	19.3	19.5	157.5	92.5	95	100
Long-Term Leases	21.18	26.65	40.29	33.73	31.85	12.71
Total Liabilities	510.83	511.2	462.26	437.06	325.75	349.76
Common Stock	0.03	0.03	0.03	0.03	0.03	0.03
Additional Paid-In Capital	-	6,081	6,081	6,081	6,081	6,023
Retained Earnings	-	-5,556	-4,965	-4,197	-3,351	-2,649
Treasury Stock	-	-0	-0	-0	-0	-0
Comprehensive Income & Other	908.58	643.91	568.36	470.84	61.37	55.54
Shareholders' Equity	908.61	1,169	1,684	2,354	2,791	3,430
Total Liabilities & Equity	1,419	1,680	2,146	2,791	3,117	3,779
Total Debt	372.46	422.4	318.8	279.13	147.04	123.59
Net Cash (Debt)	274.42	340.13	692.65	1,110	1,688	2,508
Net Cash Growth	-43.82%	-50.90%	-37.59%	-34.26%	-32.69%	-
Net Cash Per Share	0.66	0.82	1.68	2.71	4.22	19.01
Filing Date Shares Outstanding	415.63	404.7	401.56	400.2	396.79	377.07
Total Common Shares Outstanding	415.63	404.7	401.56	400.2	396.79	377.07
Working Capital	276.7	343.62	803.02	1,174	1,696	2,410
Book Value Per Share	2.19	2.89	4.19	5.88	7.03	9.10
Tangible Book Value	491.07	586.2	972.62	1,461	1,975	2,655
Tangible Book Value Per Share	1.18	1.45	2.42	3.65	4.98	7.04
Machinery	-	217.95	216.21	189.32	147.47	66.34
Construction In Progress	-	0.07	0.85	32.9	17.16	217.52
Leasehold Improvements	-	234.33	234.76	234.66	208.38	25.6

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.